Ricevi le ultime notizie sulle azioni Intellia Therapeutics con aggiornamenti su tendenze di mercato, dati finanziari e analisi di Benzinga. Rimani informato sulle performance di NTLA

Ultime notizie per

Intellia Therapeutics

Intellia Therapeutics, Inc. - Common Stock

Intellia Therapeutics Inc

AnaptysBio

BridgeBio Oncology Therapeutics, Inc. - Common Stock

BridgeBio Oncology

CureVac

Day One Biopharmaceuticals, Inc. - Common Stock

Day One Biopharmaceutical

Dynavax Technologies Corporation - Common Stock

Dynavax Technologies

Immatics

Inhibrx Biosciences

MiMedx Group

Nanobiotix

Nurix Therapeutics

Novavax

Oric Pharmaceuticals, Inc. - Common Stock

ORIC Pharmaceuticals

Oruka Therapeutics

Pharming Group N.V. - ADS, each representing 10 ordinary shares

Pharming

Relay Therapeutics

Rezolute

Sana Biotechnology

Syndax Pharmaceuticals, Inc. - Common Stock

Syndax Pharmaceuticals

Stoke Therapeutics

Tango Therapeutics

Taysha Gene Therapies, Inc. - Common Stock

Taysha Gene Therapies

Upstream Bio

UroGen Pharma

Xencor

Zymeworks

Intellia Therapeutics (NTLA) Previsione

Notizie

Utili

Quote.Nav.option-chain

Insider trading

Vendite allo scoperto

Commerci governativi

Rapporto azionario

Intellia Therapeutics is a gene-editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. Intellia is focused on using this technology to treat genetically defined diseases. It's evaluating multiple gene editing approaches using in vivo and ex vivo therapies to address diseases with high unmet medical needs, including ATTR amyloidosis, hereditary angioedema, sickle cell disease, and immuno-oncology. Intellia has formed collaborations with several companies to advance its pipeline, including narrow-moat Regeneron and wide-moat Novartis.

Comments

Intellia Therapeutics Notizie sulle azioni

Notizie

Ultime notizie per

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO